The cellular prion protein and its role in Alzheimer disease

The cellular prion protein (PrPC) is a membrane-bound glycoprotein especially abundant in the central nervous system (CNS). The scrapie prion protein (PrPSc, also termed prions) is responsible of transmissible spongiform encephalopathies (TSE), a group of neurodegenerative diseases which affect...

Full description

Bibliographic Details
Main Authors: Velayos, J.L. (José Luis), Irujo, A. (A.), Cuadrado-Tejedor, M. (Mar), Paternain, B. (B.), Moleres, F.J. (Francisco J.), Ferrer, V. (Vicente)
Format: info:eu-repo/semantics/article
Language:eng
Published: Prion. 2010
Subjects:
Online Access:https://hdl.handle.net/10171/13407
_version_ 1793400073002942464
author Velayos, J.L. (José Luis)
Irujo, A. (A.)
Cuadrado-Tejedor, M. (Mar)
Paternain, B. (B.)
Moleres, F.J. (Francisco J.)
Ferrer, V. (Vicente)
author_facet Velayos, J.L. (José Luis)
Irujo, A. (A.)
Cuadrado-Tejedor, M. (Mar)
Paternain, B. (B.)
Moleres, F.J. (Francisco J.)
Ferrer, V. (Vicente)
author_sort Velayos, J.L. (José Luis)
collection DSpace
description The cellular prion protein (PrPC) is a membrane-bound glycoprotein especially abundant in the central nervous system (CNS). The scrapie prion protein (PrPSc, also termed prions) is responsible of transmissible spongiform encephalopathies (TSE), a group of neurodegenerative diseases which affect humans and other mammal species, although the presence of PrPC is needed for the establishment and further evolution of prions. The present work compares the expression and localization of PrPC between healthy human brains and those suffering from Alzheimer disease (AD). In both situations we have observed a rostrocaudal decrease in the amount of PrPC within the CNS, both by immunoblotting and immunohistochemistry techniques. PrPC is higher expressed in our control brains than in AD cases. There was a neuronal loss and astogliosis in our AD cases. There was a tendency of a lesser expression of PrPC in AD cases than in healthy ones. And in AD cases, the intensity of the expression of the unglycosylated band is higher than the di- and monoglycosylated bands. With regards to amyloid plaques, those present in AD cases were positively labeled for PrPC, a result which is further supported by the presence of PrPC in the amyloid plaques of a transgenic line of mice mimicking AD. The work was done according to Helsinki Declaration of 1975, and approved by the Ethics Committee of the Faculty of Medicine of the University of Navarre.
format info:eu-repo/semantics/article
id oai:dadun.unav.edu:10171-13407
institution Universidad de Navarra
language eng
publishDate 2010
publisher Prion.
record_format dspace
spelling oai:dadun.unav.edu:10171-134072012-03-12T21:47:34Z The cellular prion protein and its role in Alzheimer disease Velayos, J.L. (José Luis) Irujo, A. (A.) Cuadrado-Tejedor, M. (Mar) Paternain, B. (B.) Moleres, F.J. (Francisco J.) Ferrer, V. (Vicente) cellular prion protein Alzheimer disease transgenic mice The cellular prion protein (PrPC) is a membrane-bound glycoprotein especially abundant in the central nervous system (CNS). The scrapie prion protein (PrPSc, also termed prions) is responsible of transmissible spongiform encephalopathies (TSE), a group of neurodegenerative diseases which affect humans and other mammal species, although the presence of PrPC is needed for the establishment and further evolution of prions. The present work compares the expression and localization of PrPC between healthy human brains and those suffering from Alzheimer disease (AD). In both situations we have observed a rostrocaudal decrease in the amount of PrPC within the CNS, both by immunoblotting and immunohistochemistry techniques. PrPC is higher expressed in our control brains than in AD cases. There was a neuronal loss and astogliosis in our AD cases. There was a tendency of a lesser expression of PrPC in AD cases than in healthy ones. And in AD cases, the intensity of the expression of the unglycosylated band is higher than the di- and monoglycosylated bands. With regards to amyloid plaques, those present in AD cases were positively labeled for PrPC, a result which is further supported by the presence of PrPC in the amyloid plaques of a transgenic line of mice mimicking AD. The work was done according to Helsinki Declaration of 1975, and approved by the Ethics Committee of the Faculty of Medicine of the University of Navarre. 2010-10-13T14:51:56Z 2010-10-13T14:51:56Z 2009-04-03 info:eu-repo/semantics/article https://hdl.handle.net/10171/13407 eng info:eu-repo/semantics/closedAccess Prion.
spellingShingle cellular prion protein
Alzheimer disease
transgenic mice
Velayos, J.L. (José Luis)
Irujo, A. (A.)
Cuadrado-Tejedor, M. (Mar)
Paternain, B. (B.)
Moleres, F.J. (Francisco J.)
Ferrer, V. (Vicente)
The cellular prion protein and its role in Alzheimer disease
title The cellular prion protein and its role in Alzheimer disease
title_full The cellular prion protein and its role in Alzheimer disease
title_fullStr The cellular prion protein and its role in Alzheimer disease
title_full_unstemmed The cellular prion protein and its role in Alzheimer disease
title_short The cellular prion protein and its role in Alzheimer disease
title_sort cellular prion protein and its role in alzheimer disease
topic cellular prion protein
Alzheimer disease
transgenic mice
url https://hdl.handle.net/10171/13407
work_keys_str_mv AT velayosjljoseluis thecellularprionproteinanditsroleinalzheimerdisease
AT irujoaa thecellularprionproteinanditsroleinalzheimerdisease
AT cuadradotejedormmar thecellularprionproteinanditsroleinalzheimerdisease
AT paternainbb thecellularprionproteinanditsroleinalzheimerdisease
AT moleresfjfranciscoj thecellularprionproteinanditsroleinalzheimerdisease
AT ferrervvicente thecellularprionproteinanditsroleinalzheimerdisease
AT velayosjljoseluis cellularprionproteinanditsroleinalzheimerdisease
AT irujoaa cellularprionproteinanditsroleinalzheimerdisease
AT cuadradotejedormmar cellularprionproteinanditsroleinalzheimerdisease
AT paternainbb cellularprionproteinanditsroleinalzheimerdisease
AT moleresfjfranciscoj cellularprionproteinanditsroleinalzheimerdisease
AT ferrervvicente cellularprionproteinanditsroleinalzheimerdisease